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Background
Juvenile idiopathic arthritis (JIA) is commonly complicated
by chronic uveitis that frequently leads to visual loss.
Methods
Review of the current literature on the treatment of JIA -
associated uveitis.
Results
Therapy of JIA-associated uveitis is guided by the severity
of inflammation and complications. Topical corticoster-
oids are generally used as the initial treatment. Severe
uveitis is commonly treated with immunosuppressive
drugs. Methotrexate is presently the first-choice agent. If
uveitis is not responding, another immunosuppressive
agent or biological is applied. Currently, adalimumab is
the preferred TNF-inhibitor. In refractory disease, other
biologicals are used (e.g., rituximab, tocilizumab or abata-
cept). Ocular corticosteroid injections / - implantations
are considered as “rescue therapy”.
Conclusions
Controlled studies are warranted to offer most effective
and safe therapy for children with JIA - associated uveitis.
Better knowledge of the basic mechanisms underlying the
disease and of the molecules that are important for
regulating inflammation may help to create new and more
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